Foamix Pharmaceuticals Q3 EPS $(0.41) Misses $(0.4) Estimate

Foamix Pharmaceuticals (NASDAQ:FOMX) reported quarterly losses of $(0.41) per share which missed the analyst consensus estimate of $(0.4) by 2.5 percent. This is a 7.89 percent decrease over losses of $(0.38) per share

Benzinga · 11/11/2019 11:21

Foamix Pharmaceuticals (NASDAQ:FOMX) reported quarterly losses of $(0.41) per share which missed the analyst consensus estimate of $(0.4) by 2.5 percent. This is a 7.89 percent decrease over losses of $(0.38) per share from the same period last year.